Global Nucleic Acid Testing Market

Nucleic Acid Testing Comprehensive Study by Type (Nucleic Acid Test Kits, Consumables), Nucleic Acid Test Kits (Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Polymerase Chain Reaction (PCR), Whole Genome Sequencing), Indication (Cancer, Infectious diseases, Forensic Testing, Others), End User (Hospitals and clinics, Academic & Research Organization, Pathology Laboratories, Others) Players and Region - Global Market Outlook to 2026

Nucleic Acid Testing Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 9.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Nucleic Acid Testing Market Scope
Nucleic acid testing is a molecular technique that is used for screening blood sample to reduce the chances or risk of transfusion transmitted infections during blood donation process. Also, it is used to detect cancer, infectious diseases and forensic. In 2015, World Health Organization (WHO) has estimated more than 5250 deaths were register due to influenza infection. Thus, increasing infectious diseases are responsible for growing nucleic acid testing market. Additionally, rising research funding for cancer treatment by different regional governments and private organizations are fueling the growth of the market as increasing the adoption of nucleic acid testing in cancer research programs.

According to AMA, the Global Nucleic Acid Testing market is expected to see growth rate of 9.8% and may see market size of USD3.53 Million by 2026.

The Players having a strong hold in the market are bioMerieux SA, Bio-rad Laboratories, Inc., Abbott Laboratories, Inc. and Beckman Coulter. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Nucleic Acid Testing market throughout the predicted period.

Bio-rad Laboratories, Inc. (United States), Becton Dickinson and Company (United States), Abbott Laboratories, Inc. (United States), Beckman Coulter, Inc. (United States), Illumina, Inc. (United States), Siemens Healthcare GmbH (Germany), Gen-probe, Inc. (United States), bioMérieux SA (France), Novartis International AG (Switzerland), Hoffmann-la Roche Ltd (Switzerland), Sequenom, Inc. (United States) and Tecan Group Ltd. (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Agilent Technologies (United States), Danaher Corporation (United States), Becton, Dickinson and Company (United States) and F. Hoffmann-La Roche Ltd. (Switzerland).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Nucleic Acid Testing market by Type (Nucleic Acid Test Kits and Consumables) and Region with country level break-up.

On the basis of geography, the market of Nucleic Acid Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On July 2018, Becton Dickinson had acquired TVA Medical to develop and innovate therapies for the treatment of end stage renal disease. Additionally, TVA Medical enables Becton Dickinson to offer innovative device to physicians who treat patients which are suffering from chronic kidney diseases.
On April 2019, Bio-Rad Laboratories, Inc has received approximately 510(k) (it is preclearance made by FDA to demonstrate that the device to be marketed is at least as safe and effective) from the U.S. Food and Drug Administration for Bio-Rad’s IH-500. Bio-Rad’s IH-500 system is designed for small- to medium-size laboratories and the system offers automated blood typing and screening.


Market Trend
  • Rising Adoption of Nucleic Acid Testing for Blood Screening
  • Increasing Safety Awareness Related to Blood Donation due to Increasing Infectious Diseases

Market Drivers
  • Increasing Number of Blood Donors
  • Rising Awareness of Infectious Diseases
  • Increasing Safety Concern of Donated Blood

Opportunities
  • Increasing Funding by Regional Governments and Private Organizations Results in an Innovation in Nucleic Acid Testing

Restraints
  • High Operating Cost and Capital Expenditure
  • Presence of Alternative for Nucleic Acid Testing

Challenges
  • High Cost of Nucleic Acid Testing


Key Target Audience
Healthcare industry, NGOs, Testing Laboratories and Others

Report Objectives / Segmentation Covered

By Type
  • Nucleic Acid Test Kits
  • Consumables
By Nucleic Acid Test Kits
  • Ligase Chain Reaction (LCR)
  • Transcription–mediated Amplification (TMA)
  • Polymerase Chain Reaction (PCR)
  • Whole Genome Sequencing

By Indication
  • Cancer
  • Infectious diseases
  • Forensic Testing
  • Others

By End User
  • Hospitals and clinics
  • Academic & Research Organization
  • Pathology Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Blood Donors
      • 3.2.2. Rising Awareness of Infectious Diseases
      • 3.2.3. Increasing Safety Concern of Donated Blood
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Nucleic Acid Testing
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Nucleic Acid Testing for Blood Screening
      • 3.4.2. Increasing Safety Awareness Related to Blood Donation due to Increasing Infectious Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nucleic Acid Testing, by Type, Nucleic Acid Test Kits, Indication , End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nucleic Acid Testing (Value)
      • 5.2.1. Global Nucleic Acid Testing by: Type (Value)
        • 5.2.1.1. Nucleic Acid Test Kits
        • 5.2.1.2. Consumables
      • 5.2.2. Global Nucleic Acid Testing by: Nucleic Acid Test Kits (Value)
        • 5.2.2.1. Ligase Chain Reaction (LCR)
        • 5.2.2.2. Transcription–mediated Amplification (TMA)
        • 5.2.2.3. Polymerase Chain Reaction (PCR)
        • 5.2.2.4. Whole Genome Sequencing
      • 5.2.3. Global Nucleic Acid Testing by: End User (Value)
        • 5.2.3.1. Hospitals and clinics
        • 5.2.3.2. Academic & Research Organization
        • 5.2.3.3. Pathology Laboratories
        • 5.2.3.4. Others
      • 5.2.4. Global Nucleic Acid Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Nucleic Acid Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Beckman Coulter, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Siemens Healthcare GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gen-probe, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioMérieux SA (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis International AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hoffmann-la Roche Ltd (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Sequenom, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Tecan Group Ltd. (Switzerland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Nucleic Acid Testing Sale, by Type, Nucleic Acid Test Kits, Indication , End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nucleic Acid Testing (Value)
      • 7.2.1. Global Nucleic Acid Testing by: Type (Value)
        • 7.2.1.1. Nucleic Acid Test Kits
        • 7.2.1.2. Consumables
      • 7.2.2. Global Nucleic Acid Testing by: Nucleic Acid Test Kits (Value)
        • 7.2.2.1. Ligase Chain Reaction (LCR)
        • 7.2.2.2. Transcription–mediated Amplification (TMA)
        • 7.2.2.3. Polymerase Chain Reaction (PCR)
        • 7.2.2.4. Whole Genome Sequencing
      • 7.2.3. Global Nucleic Acid Testing by: End User (Value)
        • 7.2.3.1. Hospitals and clinics
        • 7.2.3.2. Academic & Research Organization
        • 7.2.3.3. Pathology Laboratories
        • 7.2.3.4. Others
      • 7.2.4. Global Nucleic Acid Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nucleic Acid Testing: by Type(USD Million)
  • Table 2. Nucleic Acid Testing Nucleic Acid Test Kits , by Region USD Million (2015-2020)
  • Table 3. Nucleic Acid Testing Consumables , by Region USD Million (2015-2020)
  • Table 4. Nucleic Acid Testing: by Nucleic Acid Test Kits(USD Million)
  • Table 5. Nucleic Acid Testing Ligase Chain Reaction (LCR) , by Region USD Million (2015-2020)
  • Table 6. Nucleic Acid Testing Transcription–mediated Amplification (TMA) , by Region USD Million (2015-2020)
  • Table 7. Nucleic Acid Testing Polymerase Chain Reaction (PCR) , by Region USD Million (2015-2020)
  • Table 8. Nucleic Acid Testing Whole Genome Sequencing , by Region USD Million (2015-2020)
  • Table 9. Nucleic Acid Testing: by End User(USD Million)
  • Table 10. Nucleic Acid Testing Hospitals and clinics , by Region USD Million (2015-2020)
  • Table 11. Nucleic Acid Testing Academic & Research Organization , by Region USD Million (2015-2020)
  • Table 12. Nucleic Acid Testing Pathology Laboratories , by Region USD Million (2015-2020)
  • Table 13. Nucleic Acid Testing Others , by Region USD Million (2015-2020)
  • Table 14. South America Nucleic Acid Testing, by Country USD Million (2015-2020)
  • Table 15. South America Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 16. South America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 17. South America Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 18. South America Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 19. Brazil Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 20. Brazil Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 21. Brazil Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 22. Brazil Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 23. Argentina Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 24. Argentina Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 25. Argentina Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 26. Argentina Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 27. Rest of South America Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 29. Rest of South America Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 30. Rest of South America Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Nucleic Acid Testing, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 34. Asia Pacific Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 35. Asia Pacific Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 36. China Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 37. China Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 38. China Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 39. China Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 40. Japan Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 41. Japan Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 42. Japan Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 43. Japan Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 44. India Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 45. India Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 46. India Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 47. India Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 48. South Korea Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 49. South Korea Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 50. South Korea Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 51. South Korea Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 52. Taiwan Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 53. Taiwan Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 54. Taiwan Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 55. Taiwan Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 56. Australia Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 57. Australia Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 58. Australia Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 59. Australia Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 64. Europe Nucleic Acid Testing, by Country USD Million (2015-2020)
  • Table 65. Europe Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 66. Europe Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 67. Europe Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 68. Europe Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 69. Germany Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 70. Germany Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 71. Germany Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 72. Germany Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 73. France Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 74. France Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 75. France Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 76. France Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 77. Italy Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 78. Italy Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 79. Italy Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 80. Italy Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 81. United Kingdom Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 82. United Kingdom Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 83. United Kingdom Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 84. United Kingdom Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 85. Netherlands Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 86. Netherlands Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 87. Netherlands Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 88. Netherlands Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 89. Rest of Europe Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 90. Rest of Europe Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 91. Rest of Europe Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 92. Rest of Europe Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 93. MEA Nucleic Acid Testing, by Country USD Million (2015-2020)
  • Table 94. MEA Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 95. MEA Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 96. MEA Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 97. MEA Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 98. Middle East Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 99. Middle East Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 100. Middle East Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 101. Middle East Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 102. Africa Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 103. Africa Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 104. Africa Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 105. Africa Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 106. North America Nucleic Acid Testing, by Country USD Million (2015-2020)
  • Table 107. North America Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 108. North America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 109. North America Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 110. North America Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 111. United States Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 112. United States Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 113. United States Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 114. United States Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 115. Canada Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 116. Canada Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 117. Canada Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 118. Canada Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 119. Mexico Nucleic Acid Testing, by Type USD Million (2015-2020)
  • Table 120. Mexico Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2015-2020)
  • Table 121. Mexico Nucleic Acid Testing, by Indication USD Million (2015-2020)
  • Table 122. Mexico Nucleic Acid Testing, by End User USD Million (2015-2020)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Nucleic Acid Testing: by Type(USD Million)
  • Table 136. Nucleic Acid Testing Nucleic Acid Test Kits , by Region USD Million (2021-2026)
  • Table 137. Nucleic Acid Testing Consumables , by Region USD Million (2021-2026)
  • Table 138. Nucleic Acid Testing: by Nucleic Acid Test Kits(USD Million)
  • Table 139. Nucleic Acid Testing Ligase Chain Reaction (LCR) , by Region USD Million (2021-2026)
  • Table 140. Nucleic Acid Testing Transcription–mediated Amplification (TMA) , by Region USD Million (2021-2026)
  • Table 141. Nucleic Acid Testing Polymerase Chain Reaction (PCR) , by Region USD Million (2021-2026)
  • Table 142. Nucleic Acid Testing Whole Genome Sequencing , by Region USD Million (2021-2026)
  • Table 143. Nucleic Acid Testing: by End User(USD Million)
  • Table 144. Nucleic Acid Testing Hospitals and clinics , by Region USD Million (2021-2026)
  • Table 145. Nucleic Acid Testing Academic & Research Organization , by Region USD Million (2021-2026)
  • Table 146. Nucleic Acid Testing Pathology Laboratories , by Region USD Million (2021-2026)
  • Table 147. Nucleic Acid Testing Others , by Region USD Million (2021-2026)
  • Table 148. South America Nucleic Acid Testing, by Country USD Million (2021-2026)
  • Table 149. South America Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 150. South America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 151. South America Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 152. South America Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 153. Brazil Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 154. Brazil Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 155. Brazil Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 156. Brazil Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 157. Argentina Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 158. Argentina Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 159. Argentina Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 160. Argentina Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 161. Rest of South America Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 162. Rest of South America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 163. Rest of South America Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 164. Rest of South America Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 165. Asia Pacific Nucleic Acid Testing, by Country USD Million (2021-2026)
  • Table 166. Asia Pacific Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 167. Asia Pacific Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 168. Asia Pacific Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 169. Asia Pacific Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 170. China Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 171. China Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 172. China Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 173. China Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 174. Japan Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 175. Japan Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 176. Japan Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 177. Japan Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 178. India Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 179. India Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 180. India Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 181. India Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 182. South Korea Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 183. South Korea Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 184. South Korea Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 185. South Korea Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 186. Taiwan Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 187. Taiwan Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 188. Taiwan Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 189. Taiwan Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 190. Australia Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 191. Australia Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 192. Australia Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 193. Australia Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 196. Rest of Asia-Pacific Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 197. Rest of Asia-Pacific Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 198. Europe Nucleic Acid Testing, by Country USD Million (2021-2026)
  • Table 199. Europe Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 200. Europe Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 201. Europe Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 202. Europe Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 203. Germany Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 204. Germany Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 205. Germany Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 206. Germany Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 207. France Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 208. France Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 209. France Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 210. France Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 211. Italy Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 212. Italy Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 213. Italy Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 214. Italy Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 215. United Kingdom Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 216. United Kingdom Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 217. United Kingdom Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 218. United Kingdom Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 219. Netherlands Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 220. Netherlands Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 221. Netherlands Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 222. Netherlands Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 223. Rest of Europe Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 224. Rest of Europe Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 225. Rest of Europe Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 226. Rest of Europe Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 227. MEA Nucleic Acid Testing, by Country USD Million (2021-2026)
  • Table 228. MEA Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 229. MEA Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 230. MEA Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 231. MEA Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 232. Middle East Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 233. Middle East Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 234. Middle East Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 235. Middle East Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 236. Africa Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 237. Africa Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 238. Africa Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 239. Africa Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 240. North America Nucleic Acid Testing, by Country USD Million (2021-2026)
  • Table 241. North America Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 242. North America Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 243. North America Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 244. North America Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 245. United States Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 246. United States Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 247. United States Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 248. United States Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 249. Canada Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 250. Canada Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 251. Canada Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 252. Canada Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 253. Mexico Nucleic Acid Testing, by Type USD Million (2021-2026)
  • Table 254. Mexico Nucleic Acid Testing, by Nucleic Acid Test Kits USD Million (2021-2026)
  • Table 255. Mexico Nucleic Acid Testing, by Indication USD Million (2021-2026)
  • Table 256. Mexico Nucleic Acid Testing, by End User USD Million (2021-2026)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nucleic Acid Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Nucleic Acid Testing: by Nucleic Acid Test Kits USD Million (2015-2020)
  • Figure 6. Global Nucleic Acid Testing: by End User USD Million (2015-2020)
  • Figure 7. South America Nucleic Acid Testing Share (%), by Country
  • Figure 8. Asia Pacific Nucleic Acid Testing Share (%), by Country
  • Figure 9. Europe Nucleic Acid Testing Share (%), by Country
  • Figure 10. MEA Nucleic Acid Testing Share (%), by Country
  • Figure 11. North America Nucleic Acid Testing Share (%), by Country
  • Figure 12. Global Nucleic Acid Testing share by Players 2020 (%)
  • Figure 13. Global Nucleic Acid Testing share by Players (Top 3) 2020(%)
  • Figure 14. Global Nucleic Acid Testing share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bio-rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Bio-rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 20. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Beckman Coulter, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Illumina, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Siemens Healthcare GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Siemens Healthcare GmbH (Germany) Revenue: by Geography 2020
  • Figure 28. Gen-probe, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Gen-probe, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 31. BioMérieux SA (France) Revenue: by Geography 2020
  • Figure 32. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Novartis International AG (Switzerland) Revenue: by Geography 2020
  • Figure 34. Hoffmann-la Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Hoffmann-la Roche Ltd (Switzerland) Revenue: by Geography 2020
  • Figure 36. Sequenom, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Sequenom, Inc. (United States) Revenue: by Geography 2020
  • Figure 38. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 39. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 40. Global Nucleic Acid Testing: by Type USD Million (2021-2026)
  • Figure 41. Global Nucleic Acid Testing: by Nucleic Acid Test Kits USD Million (2021-2026)
  • Figure 42. Global Nucleic Acid Testing: by End User USD Million (2021-2026)
  • Figure 43. South America Nucleic Acid Testing Share (%), by Country
  • Figure 44. Asia Pacific Nucleic Acid Testing Share (%), by Country
  • Figure 45. Europe Nucleic Acid Testing Share (%), by Country
  • Figure 46. MEA Nucleic Acid Testing Share (%), by Country
  • Figure 47. North America Nucleic Acid Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-rad Laboratories, Inc. (United States)
  • Becton Dickinson and Company (United States)
  • Abbott Laboratories, Inc. (United States)
  • Beckman Coulter, Inc. (United States)
  • Illumina, Inc. (United States)
  • Siemens Healthcare GmbH (Germany)
  • Gen-probe, Inc. (United States)
  • bioMérieux SA (France)
  • Novartis International AG (Switzerland)
  • Hoffmann-la Roche Ltd (Switzerland)
  • Sequenom, Inc. (United States)
  • Tecan Group Ltd. (Switzerland)
Additional players considered in the study are as follows:
Agilent Technologies (United States) , Danaher Corporation (United States) , Becton, Dickinson and Company (United States) , F. Hoffmann-La Roche Ltd. (Switzerland)
Select User Access Type

Key Highlights of Report


Dec 2021 235 Pages 65 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nucleic Acid Testing Market Quantitative research analysis
Global Nucleic Acid Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Nucleic Acid Testing study can be customized to meet your requirements. The market size breakdown by type [Nucleic Acid Test Kits and Consumables], by end use application [].
The Nucleic Acid Testing Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Nucleic Acid Testing market is expected to see growth rate of 9.8%.

Know More About Global Nucleic Acid Testing Market Report?

Have a Query? Click Here

Other Related Reports

Neuroscience Comprehensive Study by Type (Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuro-functional analysis, Neuro-proteomic analysis, Neuro-cellular manipulation, Neuro-biochemical...
$ 3750
Healthcare Gamification Comprehensive Study by Type (Enterprise-based solutions, Consumer-based solutions), Application (Fitness management, Medical Training, Medication Management, Physical Therapy,...
$ 3500
Early Toxicity Testing Comprehensive Study by End Users (Pharmaceuticals Industry, Diagnostics Industry, Food Industry, Chemicals Industry, Cosmetics Industry, Others), Toxicity End-points (Dermal To...
$ 3750
Milk Allergy Clinical Trial Comprehensive Study by Type (Skin Prick Tests, Blood Allergen-Specific IgE Tests, Oral Food Challenge, Food Elimination Diet, Others), Application (Immediate Treatment, Ma...
$ 3750
Primary Biliary Cholangitis Treatment Comprehensive Study by Drug Type (Ursodeoxycholic acid (UDCA), Obeticholic acid (Ocaliva), Corticosteroids, Methotrexate, Others), Blood Test (Blood test, Liver...
$ 3350
Dental Sterilization Comprehensive Study by Sterilization Equipment (High-Temperature Sterilizers, Low- Temperature Sterilizers, Cleaning and Disinfectant Equipment, Washer Disinfectants, Ultrasonic ...
$ 3750